• GARD®skin
    OECD TG 442E

    THE FIRST AND ONLY Genomics and Machine-learning based in vitro skin sensitization assay

    Get a quote

  • Do you have “difficult-to-test” samples?

    UVCBs, Natural Extracts, Metals, and more

    Read more
12

Sensitization Testing with GARD®

Regulatory Toxicity Testing

Biological Evaluation of Medical Devices

The GARD® technology: An holistic approach

Learn more about the improved accuracy and human relevance

SenzaGen provides state-of-the-art non-animal tests for assessing a substance’s allergenicity. With excellent predictivity, the tests meet needs in several industries and help companies develop, produce and deliver safer, ethical and more sustainable products.

GLP Compliant Laboratory

READ MORE

Meet Us.

2024 Eurotox Recap Webinar

October 9 @ 16:00 - 17:00

ASCCT 13th Annual Meeting

October 28 - October 30
EVENT CALENDAR

Press Releases

2024 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014
01 Dec, 2021
News
IR
English
Corporate Information
Sales
Order
SenzaGen receives SEK 1m follow-on order for GARD®skin Dose-Response from one of the world’s largest cosmetics companies
02 Nov, 2021
News
IR
English
Regulatory
Listing Regulation
Corporate Action
Shares
Issuance
SenzaGen has completed the acquisition of VitroScreen S.r.l.
29 Oct, 2021
News
IR
English
Regulatory
MAR
Corporate Action
Shares
Issuance
SenzaGen completes a directed share issue of SEK 30 million
Next

News Posts

Subscribe


Prenumerera